404 related articles for article (PubMed ID: 29917167)
21. Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.
Waltering KK; Helenius MA; Sahu B; Manni V; Linja MJ; Jänne OA; Visakorpi T
Cancer Res; 2009 Oct; 69(20):8141-9. PubMed ID: 19808968
[TBL] [Abstract][Full Text] [Related]
22. Regulation of heat shock protein 70-1 expression by androgen receptor and its signaling in human prostate cancer cells.
Lu S; Tan Z; Wortman M; Lu S; Dong Z
Int J Oncol; 2010 Feb; 36(2):459-67. PubMed ID: 20043082
[TBL] [Abstract][Full Text] [Related]
23. Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells.
Sadar MD; Gleave ME
Cancer Res; 2000 Oct; 60(20):5825-31. PubMed ID: 11059779
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the effects of androgenic Chinese herbal medicines on androgen receptors and tumor growth in experimental prostate cancer models.
Zhang ZB; Ip SP; Cho WC; Hu Z; Huang YF; Luo DD; Xian YF; Lin ZX
J Ethnopharmacol; 2020 Oct; 260():113058. PubMed ID: 32525068
[TBL] [Abstract][Full Text] [Related]
25. Nuclear receptor interaction protein, a coactivator of androgen receptors (AR), is regulated by AR and Sp1 to feed forward and activate its own gene expression through AR protein stability.
Chen PH; Tsao YP; Wang CC; Chen SL
Nucleic Acids Res; 2008 Jan; 36(1):51-66. PubMed ID: 17984071
[TBL] [Abstract][Full Text] [Related]
26. Androgen up-regulates vascular endothelial growth factor expression in prostate cancer cells via an Sp1 binding site.
Eisermann K; Broderick CJ; Bazarov A; Moazam MM; Fraizer GC
Mol Cancer; 2013 Feb; 12():7. PubMed ID: 23369005
[TBL] [Abstract][Full Text] [Related]
27. G-protein alpha-s and -12 subunits are involved in androgen-stimulated PI3K activation and androgen receptor transactivation in prostate cancer cells.
Liu J; Youn H; Yang J; Du N; Liu J; Liu H; Li B
Prostate; 2011 Sep; 71(12):1276-86. PubMed ID: 21308712
[TBL] [Abstract][Full Text] [Related]
28. Androgen induction of cyclin-dependent kinase inhibitor p21 gene: role of androgen receptor and transcription factor Sp1 complex.
Lu S; Jenster G; Epner DE
Mol Endocrinol; 2000 May; 14(5):753-60. PubMed ID: 10809237
[TBL] [Abstract][Full Text] [Related]
29. Androgen receptor-mediated repression of novel target genes.
Prescott J; Jariwala U; Jia L; Cogan JP; Barski A; Pregizer S; Shen HC; Arasheben A; Neilson JJ; Frenkel B; Coetzee GA
Prostate; 2007 Sep; 67(13):1371-83. PubMed ID: 17624924
[TBL] [Abstract][Full Text] [Related]
30. Suppression of the androgen receptor function by quercetin through protein-protein interactions of Sp1, c-Jun, and the androgen receptor in human prostate cancer cells.
Yuan H; Young CY; Tian Y; Liu Z; Zhang M; Lou H
Mol Cell Biochem; 2010 Jun; 339(1-2):253-62. PubMed ID: 20148354
[TBL] [Abstract][Full Text] [Related]
31. Peroxisome proliferator-activated receptor gamma-independent suppression of androgen receptor expression by troglitazone mechanism and pharmacologic exploitation.
Yang CC; Wang YC; Wei S; Lin LF; Chen CS; Lee CC; Lin CC; Chen CS
Cancer Res; 2007 Apr; 67(7):3229-38. PubMed ID: 17409431
[TBL] [Abstract][Full Text] [Related]
32. Consulting prostate cancer cohort data uncovers transcriptional control: Regulation of the MARCH6 gene.
Coates HW; Chua NK; Brown AJ
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Nov; 1864(11):1656-1668. PubMed ID: 31422115
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-6 induces androgen responsiveness in prostate cancer cells through up-regulation of androgen receptor expression.
Lin DL; Whitney MC; Yao Z; Keller ET
Clin Cancer Res; 2001 Jun; 7(6):1773-81. PubMed ID: 11410519
[TBL] [Abstract][Full Text] [Related]
34. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP).
Koochekpour S; Lee TJ; Wang R; Culig Z; Delorme N; Caffey S; Marrero L; Aguirre J
Prostate; 2007 Feb; 67(2):178-89. PubMed ID: 17044040
[TBL] [Abstract][Full Text] [Related]
35. Androgen suppression of GnRH-stimulated rat LHbeta gene transcription occurs through Sp1 sites in the distal GnRH-responsive promoter region.
Curtin D; Jenkins S; Farmer N; Anderson AC; Haisenleder DJ; Rissman E; Wilson EM; Shupnik MA
Mol Endocrinol; 2001 Nov; 15(11):1906-17. PubMed ID: 11682622
[TBL] [Abstract][Full Text] [Related]
36. Identification of an anabolic selective androgen receptor modulator that actively induces death of androgen-independent prostate cancer cells.
Schmidt A; Meissner RS; Gentile MA; Chisamore MJ; Opas EE; Scafonas A; Cusick TE; Gambone C; Pennypacker B; Hodor P; Perkins JJ; Bai C; Ferraro D; Bettoun DJ; Wilkinson HA; Alves SE; Flores O; Ray WJ
J Steroid Biochem Mol Biol; 2014 Sep; 143():29-39. PubMed ID: 24565564
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effect of acetyl-11-keto-beta-boswellic acid on androgen receptor by interference of Sp1 binding activity in prostate cancer cells.
Yuan HQ; Kong F; Wang XL; Young CY; Hu XY; Lou HX
Biochem Pharmacol; 2008 Jun; 75(11):2112-21. PubMed ID: 18430409
[TBL] [Abstract][Full Text] [Related]
38. Krüppel-like factor 8 is a novel androgen receptor co-activator in human prostate cancer.
He HJ; Gu XF; Xu WH; Yang DJ; Wang XM; Su Y
Acta Pharmacol Sin; 2013 Feb; 34(2):282-8. PubMed ID: 23023312
[TBL] [Abstract][Full Text] [Related]
39. Regulation of FGF8 expression by the androgen receptor in human prostate cancer.
Gnanapragasam VJ; Robson CN; Neal DE; Leung HY
Oncogene; 2002 Aug; 21(33):5069-80. PubMed ID: 12140757
[TBL] [Abstract][Full Text] [Related]
40. FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells.
Takayama K; Horie-Inoue K; Ikeda K; Urano T; Murakami K; Hayashizaki Y; Ouchi Y; Inoue S
Biochem Biophys Res Commun; 2008 Sep; 374(2):388-93. PubMed ID: 18640093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]